ML19325C718

Responds to Recipient to DM Umbel Re NRC Receipt of Natl Psychopharmacology Lab,Inc Proposal in Reply to Solicitation RS-ARM-89-175 Concerning Drug Testing Program. All Proposals Being Given Equal Consideration

ML19325C718
Person / Time
Issue date:	10/05/1989
From:	Taylor J NRC OFFICE OF THE EXECUTIVE DIRECTOR FOR OPERATIONS (EDO)
To:	Duncan J HOUSE OF REP.
Shared Package
ML19325C719	List: ML19325C718 ML19325C720
References
CCS, NUDOCS 8910170209
Download: ML19325C718 (2)

Text

~

~=

Q:.:g a :..

3 ' ;[

.)h,,

UNITED STATES

- NUCLEAR REGULATORY COMMISSION '

G' E

-a

'i 5:

y W ASHINGTOid, D, C. 2f f.65

' ?%g

/

October 5,1989 L:

Z The Honorable John J. Duncan, Jr..

United States House of Representatives Washington, D.C.

20515

Dear Congressman Duncan:

I am responding to your letter of September 5, 1989, to Ms. Donna M. Umbel regarding the proposal we received f rom t%e National Psychopharmacology Laboratory, Inc. (NPL) in reply to our solicitation RS-ARM-89-175.

We appreciate NPL's interest in our Drug Testing Program. We are presently in the process of evaluating all;the proposals received in response to this-solicitation and assure you that'NPL's proposal will receive full consideration.

Each proposal is being considered in terms of the evaluation factors and relative lights set forth in the solicitation. This process assures that each prvposal is given full and equitable consideration for

. contract award.

~

I trust this information addresses your concerns.

Sincerely,

/

eb J es M. Ta or cting Executive Director for Operations Oc S S

'j i TEXT ACCll SCAN

~ 8910i7G209 891005 PDP ORG

'N ED PDC

p

=3 i

,i

,3 f:[ -

1 X

^

October 5,1989 j

i D

The Honorable John J,-Duncan, Jr.

Y.

s United States Houae of Representatives J

Washington, D.C.

20515

-y J

Dear Congressman Duncan:

I am responding to your letter of September 5, 1989, co Ms. Donna M. Umbel-regarding the proposal we received from the National Psychopharmacology Laboratory, Inc. (NPL) in reply to our solicitation RS-ARM-69-175.

We-appreciate fPL's interest in our Drug Testing Program. We are presently in the process of evaluating'all the proposals received in response to this

-solicitation and assu.e you that NPL's proposal will receive full j

consideration.

Each proposal is t'eing considered in terms of the evaluation factors and relative weights set forth in the solicitation.

This process assures that each proposal is given full and equitable consideration for contract award,

-I I trust this information addresses your concerns.

Sincerely, UNml Si;ned By:

Ju.t.J. Taylor James M. Taylor Acting Executive Director for Operations Distribution:

DMUmbel EJWiggins ELHalman'

'MJMattia PGNorry HLThompson JMTaylor OCA-SECY89-1036 EDO R/F EDO R/F (0004764)

./ a

}/

.i ;

OFFICE:ADM:DCFM:CNB2

ADM:DCPM:CN2

ADM:0 CPM:00

A0jDCRM:D

ADh 9 6/

SURNAME:DMUmbel:Je

EJWiggins

MJMattia

ELN&lmah'

PGNorry/F DATE:9/5 789

9/./89-

9/AT/89

95/89 M V89~

i

EO N /

_M

. OFFICE:DEDS SURNAME:HLThompson

JMTlallM DATE:9/ /89

&/4889 V

~

V GRTICK/ADM89175

__